BSECompany Update22h ago · 30 Oct 2026, 04:35 pm
Appointment of Mr. Ajay Sahni as the Chief Executive Officer of Gland Pharma International Pte. Ltd (Wholly owned subsidiary of Gland Pharma Limited)
Gland Pharma Ltd · 543245
✦ AI SummaryMgmt Change
Gland Pharma Ltd has appointed Mr. Ajay Sahni as the Chief Executive Officer of Gland Pharma International Pte. Ltd, effective November 2, 2026. Mr. Sahni will be responsible for Cenexi business, a wholly owned step-down subsidiary of Gland Pharma Limited.
Analysis Scores
Earnings Impact2/10
Growth Catalyst4/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Management